B. Hankey

A New Personalized Oral Cancer Survival Calculator to Estimate Risk of Death From Both Oral Cancer and Other Causes
20238 citationsauthor #2
Key Points for Clinicians About the SEER Oral Cancer Survival Calculator.
20233 citationsauthor #2
Analyzing discrete competing risks data with partially overlapping or independent data sources and nonstandard sampling schemes, with application to cancer registries
20194 citationsauthor #6
Increases in Thyroid Cancer Incidence and Mortality.
201741 citationsauthor #3
Health-care utilization by prognosis profile in a managed care setting: using the Surveillance, Epidemiology and End Results Cancer Survival Calculator SEER*CSC.
20147 citationsauthor #6
The Surveillance, Epidemiology, and End Results Cancer Survival Calculator SEER*CSC: validation in a managed care setting.
201425 citationsauthor #11
The Cancer Survival Query System: Making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnosed patients
201234 citationsauthor #14
Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.
20122,727 citationsauthor #6
Age-Adjusted US Cancer Death Rate Predictions.
20102 citationsauthor #5
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study
2008792 citationsauthor #4
Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S.
2007420 citationsauthor #3
Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies
2007193 citationsauthor #3
SEER Cancer Statistics Review, 1975-2003
20068,963 citationsauthor #12
SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD,
20061,369 citationsauthor #12
New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000.
2006600 citationsauthor #16
Possible immunological implications of an association between the stages of first and second independent breast cancers
20051 citationsauthor #2
Tissues from population-based cancer registries: a novel approach to increasing research potential.
200544 citationsauthor #13
An evaluation of the effect of vincristine added to cyclophosphamide, 5-fluorouracil, methotrexate, and prednisone in advanced breast cancer
20057 citationsauthor #2
CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray.
200583 citationsauthor #8
Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975–2000
2004354 citationsauthor #3
Partitioning linear trends in age-adjusted rates
2004343 citationsauthor #1
Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program.
2003456 citationsauthor #4
The surveillance, epidemiology, and end-results program database as a resource for conducting descriptive epidemiologic and clinical studies.
2003110 citationsauthor #2
SPECIAL ARTICLE Annual Report to the Nation on the Status of Cancer, 1975-2000, Featuring the Uses of Surveillance Data for Cancer Prevention and Control
20037 citationsauthor #3
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.
2003930 citationsauthor #3
Changing area socioeconomic patterns in U.S. cancer mortality, 1950-1998: Part I--All cancers among men.
2002116 citationsauthor #3
Changing area socioeconomic patterns in U.S. cancer mortality, 1950-1998: Part II--Lung and colorectal cancers.
2002162 citationsauthor #3
Impact of reporting delay and reporting error on cancer incidence rates and trends.
2002286 citationsauthor #5
Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women.
2002134 citationsauthor #2
Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study.
2002572 citationsauthor #3
Monitoring progress against cancer with age-adjusted rates and trends: what role does the standard population play?
20001 citationsauthor #2
Measuring the Quality of Breast Cancer Care
200087 citationsauthor #2
Measuring the quality of breast cancer care.
200018 citationsauthor #2
Partitioning linear trends in age-adjusted rates (Cancer Causes and Control 11: 31–35, 2000)
20001 citationsauthor #1
Prostate Cancer Trends 1973-1995, SEER Program National Cancer Institute.
1999169 citationsauthor #8
Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.
1999256 citationsauthor #3
Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality.
1999220 citationsauthor #6
The surveillance, epidemiology, and end results program: a national resource.
1999582 citationsauthor #1
Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
1999609 citationsauthor #1
A conversation with William M. Haenszel
19971 citationsauthor #1
Author reply
19970 citationsauthor #2
Second cancers after adjuvant tamoxifen therapy for breast cancer.
1996172 citationsauthor #4
Recent trends in U.S. breast cancer incidence, survival, and mortality rates.
1996416 citationsauthor #5
Prognostic significance of in situ carcinoma associated with invasive breast carcinoma: A natural experiment in cancer immunology?
199622 citationsauthor #3
Second malignant neoplasms among long-term survivors of ovarian cancer.
1996139 citationsauthor #5
COMMENT ON: LUNG CANCER AFTER HODGKIN'S DISEASE. AUTHORS'S REPLIES
19960 citationsauthor #5
Vaginal clear cell adenocarcinoma in the United States.
199614 citationsauthor #4
Cancer. Introduction.
19951 citationsauthor #5
Second malignancies after testicular cancer.
199515 citationsauthor #3
Anatomic site distribution of colon cancer by race and other colon cancer risk factors
199525 citationsauthor #9
Second primary cancer after treatment for cervical cancer. An international cancer registries study
1995211 citationsauthor #8
Completeness of hospital cancer case reporting from the SEER program of the national cancer institute
1995303 citationsauthor #3
Re: Lung cancer risk and radiation dose among women treated for breast cancer.
199512 citationsauthor #4
Lung cancer after Hodgkin's disease.
199539 citationsauthor #4
State Bite Age Distribution of Breast Cancer Cases
19948 citationsauthor #1
Amended Long-Term Trends in Cancer Incidence Rates in Children
19942 citationsauthor #2
Trends in breast cancer in younger women in contrast to older women.
1994158 citationsauthor #1
A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer.
1994109 citationsauthor #4
Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990.
1994192 citationsauthor #4
The significance of the rising incidence of breast cancer in the United States.
199422 citationsauthor #3
Stat BiteBrain Cancer Incidence in the Elderly, 1973–1989
19933 citationsauthor #1
Recent incidence trends for breast cancer in women and the relevanceof early detection: An update
1993137 citationsauthor #3
ACUTE NONLYMPHOCYTIC LEUKEMIA AFTER SMALL-CELL LUNG CANCER
19932 citationsauthor #3
Breast cancer among black and white women in the 1980s. Changing patterns in the United States by race, age, and extent of disease
199364 citationsauthor #4
A collaborative study of differences in the survival rates of black patients and white patients with cancer
1992118 citationsauthor #2
Stat bite: Average years of life lost per person dying of cancer.
19920 citationsauthor #1
Stat Bite Breast cancer Incidence, 1973–1989
19922 citationsauthor #1
Stat Bite : Trends in Bladder Cancer Incidence and Mortality, 1973–1989
19920 citationsauthor #1
Stat Bite : Trends in U.S. Cancer Mortality by Age Group, 1973–1989
19922 citationsauthor #1
Hodgkin's disease following non‐Hodgkin's lymphoma
199230 citationsauthor #3
Second cancers in patients with chronic lymphocytic leukemia.
1992242 citationsauthor #3
Graphical representation of survival curves associated with a binary non-reversible time dependent covariate.
199222 citationsauthor #2
Differences between black and white women with breast cancer in time from symptom recognition to medical consultation. Black/White Cancer Survival Study Group.
1992117 citationsauthor #4
The increasing incidence of breast cancer since 1982: relevance of early detection
199143 citationsauthor #3
Problems in cancer surveillance: delineating in situ and invasive bladder cancer.
199119 citationsauthor #1
Trends in Invasive Breast Cancer Incidence Among American Women
19916 citationsauthor #3
Second cancers following non‐Hodgkin's lymphoma
1991186 citationsauthor #4
Prognostic significance of cellular immunity to autologous breast carcinoma and glycoprotein 55.
198910 citationsauthor #4
An Index of Prognostically Significant Cell-Mediated Immunity
19882 citationsauthor #3
Skin window reactivity to autologous breast cancer. An index of prognostically significant cell‐mediated immunity
198823 citationsauthor #3
Black/white differences in bladder cancer patient survival.
198731 citationsauthor #1
Factors associated with survival differences between black women and white women with cancer of the uterine corpus.
198645 citationsauthor #3
Risk of leukemia associated with the first course of cancer treatment: an analysis of the Surveillance, Epidemiology, and End Results Program experience.
198485 citationsauthor #2
A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy.
1983139 citationsauthor #1
Parity as a prognostic factor in young breast cancer patients.
198336 citationsauthor #2
Changing patterns of Hodgkin's disease at autopsy: a 25-year experience at the National Cancer Institute, 1953--1978.
198213 citationsauthor #4
Stratification and the Adjusted Chi-Square Statistic: Application to Analysis of Employment Discrimination Data
19820 citationsauthor #2
Long‐term patient survival for some of the more frequently occurring cancers
198217 citationsauthor #1
Intrastage prognostic heterogeneity: implications for adjuvant chemotherapy of breast cancer.
198211 citationsauthor #2
Concepts and problems in the evaluation of screening programs.
198167 citationsauthor #2
Identification of breast cancer patients with high risk of early recurrence after radical mastectomy: III. Steroid hormones measured in urine
198010 citationsauthor #2
A lofistic rlgression analysis of response-time data where the hazard function is time dependent
197830 citationsauthor #2
Prediction of response to adrenalectomy in the treatment of advanced breast cancer.
19785 citationsauthor #3
The Odds Ratios of a 2 × 2 Contingency Table
197515 citationsauthor #2
Prognosis in breast cancer utilizing histologic characteristics of the primary tumor
1975134 citationsauthor #3
Prognosis in breast cancer utilizing histologic characteristics of the primary tumor
197595 citationsauthor #3
A logistic-exponential model for use with response-time data involving regressor variables.
197359 citationsauthor #2
Predicting survival in terminal cancer.
19734 citationsauthor #3
Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer
1972210 citationsauthor #4
Programmed Analysis of a 2×2 Contingency Table
197110 citationsauthor #2

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT